Abaloparatide

Abaloparatide (BA 058) is a selective PTHR1 analog that activates both Gs/cAMP and β-arrestin signaling pathways. It has been shown to enhance bone formation and improve cortical bone structure in murine models, demonstrating its utility for in vivo and in vitro osteoporosis research.